speb/financial-data huggingface dataset:
MD.V balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 86870758.00
MD.V income_statement (annual, 2024-09-30) — Other Gand A: 332936.00
MD.V income_statement (annual, 2024-09-30) — Other Income Expense: -1351448.00
MD.V balance_sheet (annual, 2024-09-30) — Other Investments: 500000.00
MD.V balance_sheet (quarterly, 2024-09-30) — Other Investments: 500000.00
MD.V income_statement (annual, 2024-09-30) — Other Operating Expenses: 708424.00
MD.V balance_sheet (annual, 2024-09-30) — Other Properties: 35218443.00
MD.V balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 3190481.00
MD.V balance_sheet (annual, 2024-09-30) — Payables And Accrued Expenses: 592225.00
MD.V balance_sheet (annual, 2024-09-30) — Prepaid Assets: 105563.00
MD.V income_statement (annual, 2024-09-30) — Pretax Income: -2979998.00
MD.V cash_flow (annual, 2024-09-30) — Purchase Of Investment: -2875000.00
MD.V cash_flow (annual, 2024-09-30) — Purchase Of PPE: -2924479.00
MD.V balance_sheet (annual, 2024-09-30) — Receivables: 409627.00
MD.V income_statement (annual, 2024-09-30) — Reconciled Cost Of Revenue: 29892.00
MD.V income_statement (annual, 2024-09-30) — Reconciled Depreciation: 29892.00
MD.V cash_flow (annual, 2024-09-30) — Repayment Of Debt: -34496.00
MD.V balance_sheet (annual, 2024-09-30) — Retained Earnings: -24555294.00
MD.V income_statement (annual, 2024-09-30) — Salaries And Wages: 1061429.00
MD.V cash_flow (annual, 2024-09-30) — Sale Of Investment: 2602759.00
MD.V cash_flow (annual, 2024-09-30) — Sale Of PPE: 1130000.00
MD.V income_statement (annual, 2024-09-30) — Selling General And Administration: 1394365.00
MD.V balance_sheet (annual, 2024-09-30) — Share Issued: 86870758.00
MD.V income_statement (annual, 2024-09-30) — Special Income Charges: -1349257.00
MD.V cash_flow (annual, 2024-09-30) — Stock Based Compensation: 148618.00
MD.V balance_sheet (annual, 2024-09-30) — Stockholders Equity: 39521994.00
MD.V balance_sheet (annual, 2024-09-30) — Tangible Book Value: 39521994.00
MD.V income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: -465683.90
MD.V income_statement (annual, 2024-09-30) — Tax Provision: -1026852.00
MD.V income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.34
MD.V balance_sheet (annual, 2024-09-30) — Taxes Receivable: 211885.00
MD.V balance_sheet (annual, 2024-09-30) — Total Assets: 41220324.00
MD.V balance_sheet (annual, 2024-09-30) — Total Capitalization: 39521994.00
MD.V balance_sheet (annual, 2024-09-30) — Total Debt: 16612.00
MD.V balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 39521994.00
MD.V income_statement (annual, 2024-09-30) — Total Expenses: 2132681.00
MD.V balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 1698330.00
MD.V balance_sheet (annual, 2024-09-30) — Total Non Current Assets: 35924143.00
MD.V balance_sheet (annual, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
MD.V income_statement (annual, 2024-09-30) — Total Other Finance Cost: 2492.00
MD.V income_statement (quarterly, 2024-09-30) — Total Other Finance Cost: 395.00
MD.V income_statement (annual, 2024-09-30) — Total Unusual Items: -1351448.00
MD.V income_statement (annual, 2024-09-30) — Total Unusual Items Excluding Goodwill: -1351448.00
MD.V cash_flow (annual, 2024-09-30) — Unrealized Gain Loss On Investment Securities: 2191.00
MD.V balance_sheet (annual, 2024-09-30) — Working Capital: 3597851.00
MD.V balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 205700.00
MD.V income_statement (quarterly, 2024-12-31) — Basic Average Shares: 88924497.00
MD.V income_statement (quarterly, 2024-12-31) — Basic EPS: -0.01
MD.V cash_flow (quarterly, 2024-12-31) — Depreciation: 7473.00
MD.V income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 88924497.00
MD.V income_statement (quarterly, 2024-12-31) — Diluted EPS: -0.01
MD.V income_statement (quarterly, 2024-12-31) — Interest Expense: 238.00
MD.V income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 238.00
MD.V balance_sheet (quarterly, 2024-12-31) — Other Investments: 0.00
MD.V income_statement (quarterly, 2025-03-31) — +Operating Expense: 506414.00
MD.V income_statement (quarterly, 2025-03-31) — +Total Revenue: 9906.00
MD.V balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 107111.00
MD.V balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6912571.00
MD.V cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 102339.00
MD.V balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 118950.00
MD.V income_statement (quarterly, 2025-03-31) — Basic Average Shares: 93618758.00
MD.V income_statement (quarterly, 2025-03-31) — Basic EPS: -0.01
MD.V cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 3229099.00
MD.V cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -89858.00
MD.V balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 268685.00
MD.V balance_sheet (quarterly, 2025-03-31) — Capital Stock: 59457092.00
MD.V balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 2303769.00
MD.V balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 5910192.00
MD.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -10155.00
MD.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -241796.00
MD.V cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -673379.00
MD.V cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -38614.00
MD.V cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -147630.00
MD.V cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -28855.00
MD.V cash_flow (quarterly, 2025-03-31) — Change In Receivables: -61329.00
MD.V cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -276428.00
MD.V cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -60646.00
MD.V cash_flow (quarterly, 2025-03-31) — Changes In Cash: -925330.00
MD.V balance_sheet (quarterly, 2025-03-31) — Common Stock: 59457092.00
MD.V balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 40516819.00
MD.V cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
MD.V income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 5305.00
MD.V balance_sheet (quarterly, 2025-03-31) — Current Assets: 6281852.00
MD.V balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 20870.00
MD.V balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 20870.00
MD.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1000607.00
MD.V balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1000607.00
MD.V balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1538846.00
MD.V cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -65100.00
MD.V cash_flow (quarterly, 2025-03-31) — Deferred Tax: -65100.00
MD.V cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 5305.00
MD.V cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 5305.00
MD.V income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 93618758.00
MD.V income_statement (quarterly, 2025-03-31) — Diluted EPS: -0.01
MD.V income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — EBIT: -501813.00
MD.V income_statement (quarterly, 2025-03-31) — EBITDA: -496508.00
MD.V cash_flow (quarterly, 2025-03-31) — End Cash Position: 2303769.00
MD.V cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -10155.00
MD.V cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -763237.00
MD.V income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 31625.00
MD.V income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 279279.00
MD.V balance_sheet (quarterly, 2025-03-31) — Gross PPE: 35902678.00
MD.V income_statement (quarterly, 2025-03-31) — Gross Profit: 4601.00
MD.V income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 102339.00
MD.V income_statement (quarterly, 2025-03-31) — Interest Income: 66648.00
MD.V income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 66648.00
MD.V balance_sheet (quarterly, 2025-03-31) — Invested Capital: 40516819.00
MD.V cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -241796.00
MD.V balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 118950.00
MD.V balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 118950.00
MD.V cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
MD.V balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 247815.00
MD.V balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 247815.00
MD.V cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -9162.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
MD.V income_statement (quarterly, 2025-03-31) — Net Income: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -442708.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -442708.00
MD.V income_statement (quarterly, 2025-03-31) — Net Interest Income: 64719.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: 115919.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -9162.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -9162.00
MD.V income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 64719.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -993.00
MD.V cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -267857.00
MD.V balance_sheet (quarterly, 2025-03-31) — Net PPE: 35902678.00
MD.V cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -89858.00
MD.V balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 40516819.00
MD.V income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -425794.00
MD.V income_statement (quarterly, 2025-03-31) — Normalized Income: -381059.40
MD.V cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -673379.00
MD.V income_statement (quarterly, 2025-03-31) — Operating Income: -501813.00
MD.V income_statement (quarterly, 2025-03-31) — Operating Revenue: 9906.00
MD.V balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 93618758.00
MD.V balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 353223.00
MD.V income_statement (quarterly, 2025-03-31) — Other Gand A: 43290.00
MD.V income_statement (quarterly, 2025-03-31) — Other Income Expense: -70714.00
MD.V balance_sheet (quarterly, 2025-03-31) — Other Investments: 0.00
MD.V income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 227135.00
MD.V balance_sheet (quarterly, 2025-03-31) — Other Properties: 35902678.00
MD.V balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3606423.00
MD.V balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 164146.00
MD.V balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 102229.00
MD.V income_statement (quarterly, 2025-03-31) — Pretax Income: -507808.00
MD.V cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: 0.00
MD.V cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -89858.00
MD.V balance_sheet (quarterly, 2025-03-31) — Receivables: 269431.00
MD.V income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 5305.00
MD.V income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 5305.00
MD.V cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -9162.00
MD.V balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -25852844.00
MD.V income_statement (quarterly, 2025-03-31) — Salaries And Wages: 235989.00
MD.V cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 115919.00
MD.V cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
MD.V income_statement (quarterly, 2025-03-31) — Selling General And Administration: 279279.00
MD.V balance_sheet (quarterly, 2025-03-31) — Share Issued: 93618758.00
MD.V income_statement (quarterly, 2025-03-31) — Special Income Charges: -102339.00
MD.V cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 34838.00
MD.V balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 40516819.00
MD.V balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 40516819.00
MD.V income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: -9065.40
MD.V income_statement (quarterly, 2025-03-31) — Tax Provision: -65100.00
MD.V income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.13
MD.V balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 162320.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Assets: 42303480.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 40516819.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Debt: 268685.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 40516819.00
MD.V income_statement (quarterly, 2025-03-31) — Total Expenses: 511719.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1786661.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 36021628.00
MD.V balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 247815.00
MD.V income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 1929.00
MD.V income_statement (quarterly, 2025-03-31) — Total Unusual Items: -70714.00
MD.V income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: -70714.00
MD.V cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: -31625.00
MD.V balance_sheet (quarterly, 2025-03-31) — Working Capital: 4743006.00
MD.V income_statement (quarterly, 2025-06-30) — +Operating Expense: 390425.00
MD.V income_statement (quarterly, 2025-06-30) — +Total Revenue: 63283.00
MD.V balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 84634.00
MD.V balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 6975011.00
MD.V cash_flow (quarterly, 2025-06-30) — Asset Impairment Charge: 43539.00
MD.V balance_sheet (quarterly, 2025-06-30) — Available For Sale Securities: 77400.00
MD.V income_statement (quarterly, 2025-06-30) — Basic Average Shares: 93618758.00
MD.V income_statement (quarterly, 2025-06-30) — Basic EPS: 0.00
MD.V cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 2303769.00
MD.V cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1362578.00
MD.V balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 263653.00
MD.V balance_sheet (quarterly, 2025-06-30) — Capital Stock: 59457092.00
MD.V balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3016160.00
MD.V balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 5701443.00
MD.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -5032.00
MD.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 435665.00
MD.V cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 281758.00
MD.V cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 348022.00
MD.V cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 157084.00
MD.V cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -7269.00
MD.V cash_flow (quarterly, 2025-06-30) — Change In Receivables: 8485.00
MD.V cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 506322.00
MD.V cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: 22477.00
MD.V cash_flow (quarterly, 2025-06-30) — Changes In Cash: 712391.00
MD.V balance_sheet (quarterly, 2025-06-30) — Common Stock: 59457092.00
MD.V balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 40391544.00
MD.V cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
MD.V income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 8448.00
MD.V balance_sheet (quarterly, 2025-06-30) — Current Assets: 6071887.00
MD.V balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 21623.00
MD.V balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 21623.00
MD.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1348629.00
MD.V balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1348629.00
MD.V balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 2197288.00
MD.V cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: -115300.00
MD.V cash_flow (quarterly, 2025-06-30) — Deferred Tax: -115300.00
MD.V cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 8448.00
MD.V cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 8448.00
MD.V income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 93618758.00
MD.V income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.00
MD.V income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — EBIT: -335590.00
MD.V income_statement (quarterly, 2025-06-30) — EBITDA: -327142.00
MD.V cash_flow (quarterly, 2025-06-30) — End Cash Position: 3016160.00
MD.V cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -5032.00
MD.V cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -1080820.00
MD.V income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 17818.00
MD.V income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 265395.00
MD.V balance_sheet (quarterly, 2025-06-30) — Gross PPE: 36681575.00
MD.V income_statement (quarterly, 2025-06-30) — Gross Profit: 54835.00
MD.V income_statement (quarterly, 2025-06-30) — Impairment Of Capital Assets: 43539.00
MD.V income_statement (quarterly, 2025-06-30) — Interest Income: 63803.00
MD.V income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 63803.00
MD.V balance_sheet (quarterly, 2025-06-30) — Invested Capital: 40391544.00
MD.V cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 435665.00
MD.V balance_sheet (quarterly, 2025-06-30) — Investmentin Financial Assets: 77400.00
MD.V balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 77400.00
MD.V cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
MD.V balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 242030.00
MD.V balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 242030.00
MD.V cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -5032.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
MD.V income_statement (quarterly, 2025-06-30) — Net Income: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -187715.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -187715.00
MD.V income_statement (quarterly, 2025-06-30) — Net Interest Income: 58296.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 980508.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -5032.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -5032.00
MD.V income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 58296.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
MD.V cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 817735.00
MD.V balance_sheet (quarterly, 2025-06-30) — Net PPE: 36681575.00
MD.V cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1362578.00
MD.V balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 40391544.00
MD.V income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -301421.00
MD.V income_statement (quarterly, 2025-06-30) — Normalized Income: -171781.08
MD.V cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 281758.00
MD.V income_statement (quarterly, 2025-06-30) — Operating Income: -335590.00
MD.V income_statement (quarterly, 2025-06-30) — Operating Revenue: 63283.00
MD.V balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 93618758.00
MD.V balance_sheet (quarterly, 2025-06-30) — Other Current Liabilities: 237923.00
MD.V income_statement (quarterly, 2025-06-30) — Other Gand A: 41177.00
MD.V income_statement (quarterly, 2025-06-30) — Other Income Expense: -25721.00
MD.V balance_sheet (quarterly, 2025-06-30) — Other Investments: 0.00
MD.V income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 125030.00
MD.V balance_sheet (quarterly, 2025-06-30) — Other Properties: 36681575.00
MD.V balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 2685283.00
MD.V balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 589113.00
MD.V balance_sheet (quarterly, 2025-06-30) — Prepaid Assets: 109498.00
MD.V income_statement (quarterly, 2025-06-30) — Pretax Income: -303015.00
MD.V cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
MD.V cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1362578.00
MD.V balance_sheet (quarterly, 2025-06-30) — Receivables: 260946.00
MD.V income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 8448.00
MD.V income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 8448.00
MD.V cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -5032.00
MD.V balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -26040559.00
MD.V income_statement (quarterly, 2025-06-30) — Salaries And Wages: 224218.00
MD.V cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 980508.00
MD.V cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
MD.V income_statement (quarterly, 2025-06-30) — Selling General And Administration: 265395.00
MD.V balance_sheet (quarterly, 2025-06-30) — Share Issued: 93618758.00
MD.V income_statement (quarterly, 2025-06-30) — Special Income Charges: -43539.00
MD.V cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 44282.00
MD.V balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 40391544.00
MD.V balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 40391544.00
MD.V income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: -9787.08
MD.V income_statement (quarterly, 2025-06-30) — Tax Provision: -115300.00
MD.V income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.38
MD.V balance_sheet (quarterly, 2025-06-30) — Taxes Receivable: 176312.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Assets: 42830862.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 40391544.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Debt: 263653.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 40391544.00
MD.V income_statement (quarterly, 2025-06-30) — Total Expenses: 398873.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 2439318.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 36758975.00
MD.V balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 242030.00
MD.V income_statement (quarterly, 2025-06-30) — Total Other Finance Cost: 5507.00
MD.V income_statement (quarterly, 2025-06-30) — Total Unusual Items: -25721.00
MD.V income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: -25721.00
MD.V cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -17818.00
MD.V balance_sheet (quarterly, 2025-06-30) — Working Capital: 3874599.00
MD.V income_statement (annual, 2025-09-30) — +Operating Expense: 1916023.00
MD.V income_statement (quarterly, 2025-09-30) — +Operating Expense: 460854.00
MD.V income_statement (annual, 2025-09-30) — +Total Revenue: 164488.00
MD.V income_statement (quarterly, 2025-09-30) — +Total Revenue: 85937.00
MD.V balance_sheet (annual, 2025-09-30) — Accounts Receivable: 147691.00
MD.V balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 147691.00
MD.V balance_sheet (annual, 2025-09-30) — Additional Paid In Capital: 7011061.00
MD.V balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7011061.00
MD.V cash_flow (annual, 2025-09-30) — Asset Impairment Charge: 1072954.00
MD.V cash_flow (quarterly, 2025-09-30) — Asset Impairment Charge: 751841.00
MD.V balance_sheet (annual, 2025-09-30) — Available For Sale Securities: 108360.00
MD.V balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 108360.00
MD.V income_statement (annual, 2025-09-30) — Basic Average Shares: 94974538.00
MD.V income_statement (annual, 2025-09-30) — Basic EPS: -0.02
MD.V cash_flow (annual, 2025-09-30) — Beginning Cash Position: 1590510.00
MD.V cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 3016160.00
MD.V cash_flow (annual, 2025-09-30) — Capital Expenditure: -3134613.00
MD.V cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -1539610.00
MD.V balance_sheet (annual, 2025-09-30) — Capital Lease Obligations: 258517.00
MD.V balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 258517.00
MD.V balance_sheet (annual, 2025-09-30) — Capital Stock: 64500842.00
MD.V balance_sheet (quarterly, 2025-09-30) — Capital Stock: 64500842.00
MD.V balance_sheet (annual, 2025-09-30) — Cash And Cash Equivalents: 1868473.00
MD.V balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1868473.00
MD.V balance_sheet (annual, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8556469.00
MD.V balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 8556469.00
MD.V cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Financing Activities: 8426850.00
MD.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 5958222.00
MD.V cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5813240.00
MD.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -5536252.00
MD.V cash_flow (annual, 2025-09-30) — Cash Flow From Continuing Operating Activities: -2335647.00
MD.V cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -1569657.00
MD.V cash_flow (annual, 2025-09-30) — Change In Other Working Capital: -881791.00
MD.V cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -1140927.00
MD.V cash_flow (annual, 2025-09-30) — Change In Payables And Accrued Expense: 11078.00
MD.V cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 82766.00
MD.V cash_flow (annual, 2025-09-30) — Change In Prepaid Assets: -6781.00
MD.V cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -2846.00
MD.V cash_flow (annual, 2025-09-30) — Change In Receivables: -48904.00
MD.V cash_flow (quarterly, 2025-09-30) — Change In Receivables: -226500.00
MD.V cash_flow (annual, 2025-09-30) — Change In Working Capital: -926398.00
MD.V cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1287507.00
MD.V cash_flow (annual, 2025-09-30) — Changes In Account Receivables: 50051.00
MD.V cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -63057.00
MD.V cash_flow (annual, 2025-09-30) — Changes In Cash: 277963.00
MD.V cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1147687.00
MD.V balance_sheet (annual, 2025-09-30) — Common Stock: 64500842.00
MD.V balance_sheet (quarterly, 2025-09-30) — Common Stock: 64500842.00
MD.V balance_sheet (annual, 2025-09-30) — Common Stock Equity: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 44529697.00
MD.V cash_flow (annual, 2025-09-30) — Common Stock Issuance: 8757950.00
MD.V cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 6108750.00
MD.V income_statement (annual, 2025-09-30) — Cost Of Revenue: 29674.00
MD.V income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 8448.00
MD.V balance_sheet (annual, 2025-09-30) — Current Assets: 9192839.00
MD.V balance_sheet (quarterly, 2025-09-30) — Current Assets: 9192839.00
MD.V balance_sheet (annual, 2025-09-30) — Current Capital Lease Obligation: 22392.00
MD.V balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 22392.00
MD.V balance_sheet (annual, 2025-09-30) — Current Debt And Capital Lease Obligation: 22392.00
MD.V balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 22392.00
MD.V balance_sheet (annual, 2025-09-30) — Current Deferred Liabilities: 207702.00
MD.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 207702.00
MD.V balance_sheet (annual, 2025-09-30) — Current Deferred Revenue: 207702.00
MD.V balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 207702.00
MD.V balance_sheet (annual, 2025-09-30) — Current Liabilities: 2020165.00
MD.V balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2020165.00
MD.V cash_flow (annual, 2025-09-30) — Deferred Income Tax: -428710.00
MD.V cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: -238023.00
MD.V cash_flow (annual, 2025-09-30) — Deferred Tax: -428710.00
MD.V cash_flow (quarterly, 2025-09-30) — Deferred Tax: -238023.00
MD.V cash_flow (annual, 2025-09-30) — Depreciation: 29674.00
MD.V cash_flow (quarterly, 2025-09-30) — Depreciation: 8448.00
MD.V cash_flow (annual, 2025-09-30) — Depreciation Amortization Depletion: 29674.00
MD.V cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 8448.00
MD.V cash_flow (annual, 2025-09-30) — Depreciation And Amortization: 29674.00
MD.V cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 8448.00
MD.V income_statement (annual, 2025-09-30) — Diluted Average Shares: 94974538.00
MD.V income_statement (annual, 2025-09-30) — Diluted EPS: -0.02
MD.V income_statement (annual, 2025-09-30) — Diluted NI Availto Com Stockholders: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -796255.00
MD.V income_statement (annual, 2025-09-30) — EBIT: -1781209.00
MD.V income_statement (quarterly, 2025-09-30) — EBIT: -383365.00
MD.V income_statement (annual, 2025-09-30) — EBITDA: -1751535.00
MD.V income_statement (quarterly, 2025-09-30) — EBITDA: -374917.00
MD.V cash_flow (annual, 2025-09-30) — End Cash Position: 1868473.00
MD.V cash_flow (quarterly, 2025-09-30) — End Cash Position: 1868473.00
MD.V cash_flow (annual, 2025-09-30) — Financing Cash Flow: 8426850.00
MD.V cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 5958222.00
MD.V cash_flow (annual, 2025-09-30) — Free Cash Flow: -5470260.00
MD.V cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3109267.00
MD.V income_statement (annual, 2025-09-30) — Gain On Sale Of Security: 80402.00
MD.V income_statement (quarterly, 2025-09-30) — Gain On Sale Of Security: 33673.00
MD.V income_statement (annual, 2025-09-30) — General And Administrative Expense: 1266160.00
MD.V income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 338069.00
MD.V balance_sheet (annual, 2025-09-30) — Gross PPE: 37325646.00
MD.V balance_sheet (quarterly, 2025-09-30) — Gross PPE: 37325646.00
MD.V income_statement (annual, 2025-09-30) — Gross Profit: 134814.00
MD.V income_statement (quarterly, 2025-09-30) — Gross Profit: 77489.00
MD.V income_statement (annual, 2025-09-30) — Impairment Of Capital Assets: 1072954.00
MD.V income_statement (quarterly, 2025-09-30) — Impairment Of Capital Assets: 751841.00
MD.V income_statement (annual, 2025-09-30) — Interest Income: 233882.00
MD.V income_statement (quarterly, 2025-09-30) — Interest Income: 72658.00
MD.V income_statement (annual, 2025-09-30) — Interest Income Non Operating: 233882.00
MD.V income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 72658.00
MD.V balance_sheet (annual, 2025-09-30) — Invested Capital: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Invested Capital: 44529697.00
MD.V cash_flow (annual, 2025-09-30) — Investing Cash Flow: -5813240.00
MD.V cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -5536252.00
MD.V balance_sheet (annual, 2025-09-30) — Investmentin Financial Assets: 108360.00
MD.V balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 108360.00
MD.V balance_sheet (annual, 2025-09-30) — Investments And Advances: 108360.00
MD.V balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 108360.00
MD.V cash_flow (annual, 2025-09-30) — Issuance Of Capital Stock: 8757950.00
MD.V cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 6108750.00
MD.V balance_sheet (annual, 2025-09-30) — Long Term Capital Lease Obligation: 236125.00
MD.V balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 236125.00
MD.V balance_sheet (annual, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 236125.00
MD.V balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 236125.00
MD.V cash_flow (annual, 2025-09-30) — Long Term Debt Payments: -28434.00
MD.V cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -5136.00
MD.V cash_flow (annual, 2025-09-30) — Net Common Stock Issuance: 8757950.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 6108750.00
MD.V income_statement (annual, 2025-09-30) — Net Income: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Net Income: -796255.00
MD.V income_statement (annual, 2025-09-30) — Net Income Common Stockholders: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -796255.00
MD.V income_statement (annual, 2025-09-30) — Net Income Continuous Operations: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -796255.00
MD.V income_statement (annual, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -796255.00
MD.V income_statement (annual, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -796255.00
MD.V cash_flow (annual, 2025-09-30) — Net Income From Continuing Operations: -2124246.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -796255.00
MD.V income_statement (annual, 2025-09-30) — Net Income Including Noncontrolling Interests: -2124246.00
MD.V income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -796255.00
MD.V income_statement (annual, 2025-09-30) — Net Interest Income: 220805.00
MD.V income_statement (quarterly, 2025-09-30) — Net Interest Income: 67255.00
MD.V cash_flow (annual, 2025-09-30) — Net Investment Purchase And Sale: -2819773.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -4000000.00
MD.V cash_flow (annual, 2025-09-30) — Net Issuance Payments Of Debt: -28434.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -5136.00
MD.V cash_flow (annual, 2025-09-30) — Net Long Term Debt Issuance: -28434.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -5136.00
MD.V income_statement (annual, 2025-09-30) — Net Non Operating Interest Income Expense: 220805.00
MD.V income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 67255.00
MD.V cash_flow (annual, 2025-09-30) — Net Other Financing Charges: -302666.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -145392.00
MD.V cash_flow (annual, 2025-09-30) — Net Other Investing Changes: -96354.00
MD.V cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: -159142.00
MD.V balance_sheet (annual, 2025-09-30) — Net PPE: 37325646.00
MD.V balance_sheet (quarterly, 2025-09-30) — Net PPE: 37325646.00
MD.V cash_flow (annual, 2025-09-30) — Net PPE Purchase And Sale: -2897113.00
MD.V cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1377110.00
MD.V balance_sheet (annual, 2025-09-30) — Net Tangible Assets: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 44529697.00
MD.V balance_sheet (annual, 2025-09-30) — Non Current Prepaid Assets: 159142.00
MD.V balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 159142.00
MD.V income_statement (annual, 2025-09-30) — Normalized EBITDA: -758983.00
MD.V income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 343251.00
MD.V income_statement (annual, 2025-09-30) — Normalized Income: -1298370.19
MD.V income_statement (quarterly, 2025-09-30) — Normalized Income: -243362.20
MD.V cash_flow (annual, 2025-09-30) — Operating Cash Flow: -2335647.00
MD.V cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -1569657.00
MD.V income_statement (annual, 2025-09-30) — Operating Income: -1781209.00
MD.V income_statement (quarterly, 2025-09-30) — Operating Income: -383365.00
MD.V income_statement (annual, 2025-09-30) — Operating Revenue: 164488.00
MD.V income_statement (quarterly, 2025-09-30) — Operating Revenue: 85937.00
MD.V balance_sheet (annual, 2025-09-30) — Ordinary Shares Number: 107450577.00
MD.V balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 107450577.00
MD.V balance_sheet (annual, 2025-09-30) — Other Current Liabilities: 1064900.00
MD.V balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 1064900.00
MD.V income_statement (annual, 2025-09-30) — Other Gand A: 275492.00
MD.V income_statement (quarterly, 2025-09-30) — Other Gand A: 126199.00
MD.V income_statement (annual, 2025-09-30) — Other Income Expense: -992552.00
MD.V income_statement (quarterly, 2025-09-30) — Other Income Expense: -718168.00
MD.V balance_sheet (annual, 2025-09-30) — Other Investments: 0.00
MD.V balance_sheet (quarterly, 2025-09-30) — Other Investments: 0.00
MD.V income_statement (annual, 2025-09-30) — Other Operating Expenses: 649863.00
MD.V income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 122785.00
MD.V balance_sheet (annual, 2025-09-30) — Other Properties: 37325646.00
MD.V balance_sheet (quarterly, 2025-09-30) — Other Properties: 37325646.00
MD.V balance_sheet (annual, 2025-09-30) — Other Short Term Investments: 6687996.00
MD.V balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 6687996.00
MD.V balance_sheet (annual, 2025-09-30) — Payables And Accrued Expenses: 725171.00
MD.V balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 725171.00
MD.V balance_sheet (annual, 2025-09-30) — Prepaid Assets: 112344.00
MD.V balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 112344.00
MD.V income_statement (annual, 2025-09-30) — Pretax Income: -2552956.00
MD.V income_statement (quarterly, 2025-09-30) — Pretax Income: -1034278.00
MD.V cash_flow (annual, 2025-09-30) — Purchase Of Investment: -6571200.00
MD.V cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -4000000.00
MD.V cash_flow (annual, 2025-09-30) — Purchase Of PPE: -3134613.00
MD.V cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1539610.00
MD.V balance_sheet (annual, 2025-09-30) — Receivables: 524026.00
MD.V balance_sheet (quarterly, 2025-09-30) — Receivables: 524026.00
MD.V income_statement (annual, 2025-09-30) — Reconciled Cost Of Revenue: 29674.00
MD.V income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 8448.00
MD.V income_statement (annual, 2025-09-30) — Reconciled Depreciation: 29674.00
MD.V income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 8448.00
MD.V cash_flow (annual, 2025-09-30) — Repayment Of Debt: -28434.00
MD.V cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -5136.00
MD.V balance_sheet (annual, 2025-09-30) — Retained Earnings: -26982206.00
MD.V balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -26982206.00
MD.V income_statement (annual, 2025-09-30) — Salaries And Wages: 990668.00
MD.V income_statement (quarterly, 2025-09-30) — Salaries And Wages: 211870.00
MD.V cash_flow (annual, 2025-09-30) — Sale Of Investment: 3751427.00
MD.V cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 0.00
MD.V cash_flow (annual, 2025-09-30) — Sale Of PPE: 237500.00
MD.V cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 162500.00
MD.V income_statement (annual, 2025-09-30) — Selling General And Administration: 1266160.00
MD.V income_statement (quarterly, 2025-09-30) — Selling General And Administration: 338069.00
MD.V balance_sheet (annual, 2025-09-30) — Share Issued: 107450577.00
MD.V balance_sheet (quarterly, 2025-09-30) — Share Issued: 107450577.00
MD.V income_statement (annual, 2025-09-30) — Special Income Charges: -1072954.00
MD.V income_statement (quarterly, 2025-09-30) — Special Income Charges: -751841.00
MD.V cash_flow (annual, 2025-09-30) — Stock Based Compensation: 121481.00
MD.V cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 25512.00
MD.V balance_sheet (annual, 2025-09-30) — Stockholders Equity: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 44529697.00
MD.V balance_sheet (annual, 2025-09-30) — Tangible Book Value: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 44529697.00
MD.V income_statement (annual, 2025-09-30) — Tax Effect Of Unusual Items: -166676.19
MD.V income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -165275.20
MD.V income_statement (annual, 2025-09-30) — Tax Provision: -428710.00
MD.V income_statement (quarterly, 2025-09-30) — Tax Provision: -238023.00
MD.V income_statement (annual, 2025-09-30) — Tax Rate For Calcs: 0.17
MD.V income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.23
MD.V balance_sheet (annual, 2025-09-30) — Taxes Receivable: 376335.00
MD.V balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 376335.00
MD.V balance_sheet (annual, 2025-09-30) — Total Assets: 46785987.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Assets: 46785987.00
MD.V balance_sheet (annual, 2025-09-30) — Total Capitalization: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 44529697.00
MD.V balance_sheet (annual, 2025-09-30) — Total Debt: 258517.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Debt: 258517.00
MD.V balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 44529697.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 44529697.00
MD.V income_statement (annual, 2025-09-30) — Total Expenses: 1945697.00
MD.V income_statement (quarterly, 2025-09-30) — Total Expenses: 469302.00
MD.V balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 2256290.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2256290.00
MD.V balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 37593148.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 37593148.00
MD.V balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 236125.00
MD.V balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 236125.00
MD.V income_statement (annual, 2025-09-30) — Total Other Finance Cost: 13077.00
MD.V income_statement (quarterly, 2025-09-30) — Total Other Finance Cost: 5403.00
MD.V income_statement (annual, 2025-09-30) — Total Unusual Items: -992552.00
MD.V income_statement (quarterly, 2025-09-30) — Total Unusual Items: -718168.00
MD.V income_statement (annual, 2025-09-30) — Total Unusual Items Excluding Goodwill: -992552.00
MD.V income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -718168.00
MD.V cash_flow (annual, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -80402.00
MD.V cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -33673.00
MD.V balance_sheet (annual, 2025-09-30) — Working Capital: 7172674.00
MD.V balance_sheet (quarterly, 2025-09-30) — Working Capital: 7172674.00
MD.V income_statement (quarterly, 2025-12-31) — +Operating Expense: 587197.00
MD.V income_statement (quarterly, 2025-12-31) — +Total Revenue: 211900.00
MD.V balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 101286.00
MD.V balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 7032995.00
MD.V cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 405995.00
MD.V income_statement (quarterly, 2025-12-31) — Basic Average Shares: 108831296.00
MD.V income_statement (quarterly, 2025-12-31) — Basic EPS: -0.01
MD.V cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1868473.00
MD.V cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -114294.00
MD.V balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 253273.00
MD.V balance_sheet (quarterly, 2025-12-31) — Capital Stock: 67016501.00
MD.V balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 6268855.00
MD.V balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 10422464.00
MD.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 2853386.00
MD.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 2064470.00
MD.V cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -517474.00
MD.V cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -185040.00
MD.V cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -24785.00
MD.V cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 32580.00
MD.V cash_flow (quarterly, 2025-12-31) — Change In Receivables: 143996.00
MD.V cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -33249.00
MD.V cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 46405.00
MD.V cash_flow (quarterly, 2025-12-31) — Changes In Cash: 4400382.00
MD.V balance_sheet (quarterly, 2025-12-31) — Common Stock: 67016501.00
MD.V balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 46341013.00
MD.V cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 3037811.00
MD.V income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 8448.00
MD.V balance_sheet (quarterly, 2025-12-31) — Current Assets: 11112516.00
MD.V balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 23176.00
MD.V balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 23176.00
MD.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 22662.00
MD.V balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 22662.00
MD.V balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 1878924.00
MD.V cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -141110.00
MD.V cash_flow (quarterly, 2025-12-31) — Deferred Tax: -141110.00
MD.V cash_flow (quarterly, 2025-12-31) — Depreciation: 8448.00
MD.V cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 8448.00
MD.V cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 8448.00
MD.V income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 108831296.00
MD.V income_statement (quarterly, 2025-12-31) — Diluted EPS: -0.01
MD.V income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -547096.00
MD.V income_statement (quarterly, 2025-12-31) — EBIT: -682911.00
MD.V income_statement (quarterly, 2025-12-31) — EBITDA: -674463.00
MD.V cash_flow (quarterly, 2025-12-31) — End Cash Position: 6268855.00
MD.V cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 2853386.00
MD.V cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -631768.00
MD.V cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -197493.00
MD.V income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 28453.00
MD.V income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 406266.00
MD.V balance_sheet (quarterly, 2025-12-31) — Gross PPE: 37337518.00